Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Laimer

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Obesity (Silver Spring, Md.)|May 15, 2007
Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parametersJulia Engl, Thomas Bobbert, Christian Ciardi, et al.
Frontiers in Endocrinology|July 24, 2023
Effectiveness of a real-life program (DIAfit) to promote physical activity in patients with type 2 diabetes: a pragmatic cluster randomized clinical trialAmar Arhab, Nicolas Junod, Jean-Benoit Rossel, et al.
Obesity (Silver Spring, Md.)|June 7, 2008
A-FABP--a biomarker associated with the metabolic syndrome and/or an indicator of weight change?Julia Engl, Christian Ciardi, Tobias Tatarczyk, et al.
Swiss Medical Weekly|October 16, 2025
Swiss Diabetes and Technology recommendationsGiacomo Gastaldi, Lia Bally, Marie-Anne Burckhardt, et al.
Diabetes, Obesity & Metabolism|August 14, 2024
Clinical evidence for high-risk CE-marked medical devices for glucose management: A systematic review and meta-analysisArjola Bano, Juri Künzler, Faina Wehrli, et al.
Journal of Clinical Psychopharmacology|March 2, 2005
Olanzapine-induced hyperglycemia: role of humoral insulin resistance-inducing factorsMarkus Laimer, Christoph F Ebenbichler, Michael Kranebitter, et al.
Diabetes, Obesity & Metabolism|February 15, 2023
Machine learning for non-invasive sensing of hypoglycaemia while driving in people with diabetesVera Lehmann, Thomas Zueger, Martin Maritsch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic IssuesMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine TumorsMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Diabetes, Obesity & Metabolism|March 3, 2023
Identification of predictive factors of diabetic ketoacidosis in type 1 diabetes using a subgroup discovery algorithmAngela Ibald-Mulli, Jochen Seufert, Julia M Grimsmann, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Obesity (Silver Spring, Md.)|May 15, 2007
Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parametersJulia Engl, Thomas Bobbert, Christian Ciardi, et al.
Frontiers in Endocrinology|July 24, 2023
Effectiveness of a real-life program (DIAfit) to promote physical activity in patients with type 2 diabetes: a pragmatic cluster randomized clinical trialAmar Arhab, Nicolas Junod, Jean-Benoit Rossel, et al.
Obesity (Silver Spring, Md.)|June 7, 2008
A-FABP--a biomarker associated with the metabolic syndrome and/or an indicator of weight change?Julia Engl, Christian Ciardi, Tobias Tatarczyk, et al.
Swiss Medical Weekly|October 16, 2025
Swiss Diabetes and Technology recommendationsGiacomo Gastaldi, Lia Bally, Marie-Anne Burckhardt, et al.
Diabetes, Obesity & Metabolism|August 14, 2024
Clinical evidence for high-risk CE-marked medical devices for glucose management: A systematic review and meta-analysisArjola Bano, Juri Künzler, Faina Wehrli, et al.
Journal of Clinical Psychopharmacology|March 2, 2005
Olanzapine-induced hyperglycemia: role of humoral insulin resistance-inducing factorsMarkus Laimer, Christoph F Ebenbichler, Michael Kranebitter, et al.
Diabetes, Obesity & Metabolism|February 15, 2023
Machine learning for non-invasive sensing of hypoglycaemia while driving in people with diabetesVera Lehmann, Thomas Zueger, Martin Maritsch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic IssuesMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine TumorsMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Diabetes, Obesity & Metabolism|March 3, 2023
Identification of predictive factors of diabetic ketoacidosis in type 1 diabetes using a subgroup discovery algorithmAngela Ibald-Mulli, Jochen Seufert, Julia M Grimsmann, et al.
Pageof 9